论文部分内容阅读
目的:观察中西医结合治疗非酒精性脂肪性肝病的临床疗效。方法:选择非酒精性脂肪性肝病患者90例,随机分为治疗组(45例)、对照组(45例),其中对照组用水飞蓟宾胶囊治疗,治疗组在对照组的基础上加用疏肝消脂方。两组治疗12周后观察患者临床症状和体征、肝功能、体重质量指数、血脂等指标的变化情况。结果:两组均能改善临床症状和体征、肝功能,治疗组优于对照组,差异具有显著性意义(P<0.01);在改善血脂、体重质量指数方面,治疗组治疗后较治疗前有明显改善,差异具有显著性意义(P<0.01),对照组治疗前后无明显差异(P>0.05)。结论:中西医结合治疗非酒精性脂肪性肝病的临床疗效确切,可明显改善患者临床症状和体征、降低肝功能、血脂指标以及体重质量指数,其疗效优于单用水飞蓟宾胶囊。
Objective: To observe the clinical efficacy of integrated traditional Chinese and western medicine in the treatment of non-alcoholic fatty liver disease. Methods: Ninety patients with non-alcoholic fatty liver disease were randomly divided into treatment group (45 cases) and control group (45 cases), in which the control group was treated with silybin capsule. The treatment group was added on the basis of the control group Shugan Cellulite. After 12 weeks of treatment, the changes of clinical symptoms and signs, liver function, body mass index, blood lipid and other indexes were observed. Results: The two groups were able to improve the clinical symptoms and signs, liver function, the treatment group than the control group, the difference was significant (P <0.01); in improving the lipid, body mass index, the treatment group than before treatment The difference was significant (P <0.01). There was no significant difference in the control group before and after treatment (P> 0.05). Conclusion: Integrative treatment of non-alcoholic fatty liver disease clinical curative effect can be significantly improved in patients with clinical symptoms and signs, reduce liver function, blood lipid indicators and body mass index, the effect is superior to single silybin capsules.